These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16911137)

  • 1. Decision aids for familial breast cancer: exploring women's views using focus groups.
    Rapport F; Iredale R; Jones W; Sivell S; Edwards A; Gray J; Elwyn G
    Health Expect; 2006 Sep; 9(3):232-44. PubMed ID: 16911137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the requirements for a decision aid on familial breast cancer in the UK context: a qualitative study with patients referred to a cancer genetics service.
    Iredale R; Rapport F; Sivell S; Jones W; Edwards A; Gray J; Elwyn G
    J Eval Clin Pract; 2008 Feb; 14(1):110-5. PubMed ID: 18211652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactive patient decision aids for women facing genetic testing for familial breast cancer: a systematic web and literature review.
    Williams L; Jones W; Elwyn G; Edwards A
    J Eval Clin Pract; 2008 Feb; 14(1):70-4. PubMed ID: 18211647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the black box of a decision aid: what information do patients select from an interactive Cd-Rom on treatment options in breast cancer?
    Molenaar S; Sprangers M; Oort F; Rutgers E; Luiten E; Mulder J; van Meeteren M; de Haes H
    Patient Educ Couns; 2007 Jan; 65(1):122-30. PubMed ID: 16945498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overdetection in breast cancer screening: development and preliminary evaluation of a decision aid.
    Hersch J; Jansen J; Barratt A; Irwig L; Houssami N; Jacklyn G; Thornton H; Dhillon H; McCaffery K
    BMJ Open; 2014 Sep; 4(9):e006016. PubMed ID: 25256188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why Breast Cancer Risk by the Numbers Is Not Enough: Evaluation of a Decision Aid in Multi-Ethnic, Low-Numerate Women.
    Kukafka R; Yi H; Xiao T; Thomas P; Aguirre A; Smalletz C; David R; Crew K
    J Med Internet Res; 2015 Jul; 17(7):e165. PubMed ID: 26175193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic testing for susceptibility to breast cancer: findings from women's focus groups.
    Tessaro I; Borstelmann N; Regan K; Rimer BK; Winer E
    J Womens Health; 1997 Jun; 6(3):317-27. PubMed ID: 9201666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and pilot testing of two decision aids for individuals considering genetic testing for cancer risk.
    Wakefield CE; Meiser B; Homewood J; Peate M; Kirk J; Warner B; Lobb E; Gaff C; Tucker K
    J Genet Couns; 2007 Jun; 16(3):325-39. PubMed ID: 17318456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A qualitative study on Singaporean women's views towards breast cancer screening and Single Nucleotide Polymorphisms (SNPs) gene testing to guide personalised screening strategies.
    Wong XY; Chong KJ; van Til JA; Wee HL
    BMC Cancer; 2017 Nov; 17(1):776. PubMed ID: 29162038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Black and Minority Ethnic women's decision-making for risk reduction strategies after BRCA testing: Use of context and knowledge.
    Machirori M; Patch C; Metcalfe A
    Eur J Med Genet; 2019 May; 62(5):376-384. PubMed ID: 30550831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
    Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
    JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions.
    Wilson BJ; Torrance N; Mollison J; Wordsworth S; Gray JR; Haites NE; Grant A; Campbell MK; Miedyzbrodzka Z; Clarke A; Watson MS; Douglas A
    Health Technol Assess; 2005 Feb; 9(3):iii-iv, 1-126. PubMed ID: 15694064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decision aids for people facing health treatment or screening decisions.
    Stacey D; Légaré F; Col NF; Bennett CL; Barry MJ; Eden KB; Holmes-Rovner M; Llewellyn-Thomas H; Lyddiatt A; Thomson R; Trevena L; Wu JH
    Cochrane Database Syst Rev; 2014 Jan; (1):CD001431. PubMed ID: 24470076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of decision aids developed for women at average risk of breast cancer eligible for mammographic screening: Systematic review and assessment according to the International Patient Decision Aid Standards instrument.
    Hild S; Johanet M; Valenza A; Thabaud M; Laforest F; Ferrat E; Rat C;
    Cancer; 2020 Jun; 126(12):2765-2774. PubMed ID: 32267546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A qualitative study on a decision aid for breast cancer screening: Views from women and health professionals.
    Toledo-Chávarri A; Rué M; Codern-Bové N; Carles-Lavila M; Perestelo-Pérez L; Pérez-Lacasta MJ; Feijoo-Cid M;
    Eur J Cancer Care (Engl); 2017 May; 26(3):. PubMed ID: 28145105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Women's perceptions of personalized risk-based breast cancer screening and prevention: An international focus group study.
    Rainey L; Jervaeus A; Donnelly LS; Evans DG; Hammarström M; Hall P; Wengström Y; Broeders MJM; van der Waal D
    Psychooncology; 2019 May; 28(5):1056-1062. PubMed ID: 30848018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of two evidence-based decision aids for female BRCA1/2 mutation carriers in Germany: study protocol for a randomised controlled parallel-group trial.
    Kautz-Freimuth S; Redaèlli M; Isselhard A; Shukri A; Vodermaier A; Rhiem K; Schmutzler R; Stock S
    Trials; 2022 Feb; 23(1):157. PubMed ID: 35172875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of decision aids for female BRCA1 and BRCA2 mutation carriers in Germany to support preference-sensitive decision-making.
    Kautz-Freimuth S; Redaèlli M; Rhiem K; Vodermaier A; Krassuski L; Nicolai K; Schnepper M; Kuboth V; Dick J; Vennedey V; Wiedemann R; Schmutzler R; Stock S
    BMC Med Inform Decis Mak; 2021 Jun; 21(1):180. PubMed ID: 34090422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and pilot testing of a decision aid for men considering genetic testing for breast and/or ovarian cancer-related mutations (BRCA1/2).
    Juan AS; Wakefield CE; Kasparian NA; Kirk J; Tyler J; Tucker K
    Genet Test; 2008 Dec; 12(4):523-32. PubMed ID: 19072564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Getting to the point: what women newly diagnosed with breast cancer want to know about treatment-focused genetic testing.
    Meiser B; Gleeson M; Watts K; Peate M; Zilliacus E; Barlow-Stewart K; Saunders C; Mitchell G; Kirk J
    Oncol Nurs Forum; 2012 Mar; 39(2):E101-11. PubMed ID: 22374498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.